Global HTA and CER Forum 2011

HTA, Health Technology Assessment, CER, reimbursment, comparative effectiveness

16 speakers

12 sessions

Monday 8th August 2011

• 9:00am The Role Of NICE In The Provision of Access to Innovative Healthcare: An Update

  presented by Meindert Boysen

• 10:15am Integrating Comparative Effectiveness Research in Review Processes

  presented by Jean R. Slutsky and Jean R. Slutsky

Wednesday 10th August 2011

• 9:00am HTA in Spain: What Have we Learnt of HTA in a Decentralised Country

  presented by Antonio Sarria-Santamera

• 10:15am Patented Medicine Prices Review Board – in Canada

  presented by Michelle Boudreau

Monday 15th August 2011

• 9:00am Challenges With Subgroup Analyses To Support Health Technology Assessment

  presented by Carol Reid

• 10:15am Genuine Issues Of Debate Within Health Technology Assessments: Getting It Right

  presented by Matt Stevenson

Wednesday 17th August 2011

• 9:00am How to Reconcile Value Assessment With Payers Fragmentation - An Industry Perspective

  presented by Andrea Rappagliosi

• 10:15am CASE STUDY: HTA In Ireland: The HICQ’s Perspective

  presented by Máirín Ryan

Monday 22nd August 2011

• 9:00am Performance-Based Reimbursement: The Here, Now and Ever-After?

• 10:15am Value-Based Pricing for Pharmaceuticals: Its Role, Specification and Prospects in a Newly Devolved NHS

  presented by Karl Claxton

Wednesday 24th August 2011

• 9:00am HTA and Value-Based Pricing in Europe: Major Trends and Implications for the Research Based Pharmaceutical Industry

  presented by Ansgar Hebborn

Wednesday 31st August 2011

• 9:00am Designing Product Development Programmes to Maximise Reimbursement Success

13 known attendees

1 person tracking this event